Grace Therapeutics (GRCE)

Profile

Full Name

Grace Therapeutics, Inc.

Ticker Symbol

GRCE

Exchange

NASDAQ

Country

United States

IPO

February 7, 2012

Indexes

Not included

Employees

4

Key Details

Price

$2.04(-5.56%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.73(+69.70% YoY)

PE ratio

-

Next earnings date

Jun 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 18, 25 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Grace Therapeutics?
  • Does Grace Therapeutics pay dividends?
  • What sector is Grace Therapeutics in?
  • What industry is Grace Therapeutics in?
  • What country is Grace Therapeutics based in?
  • When did Grace Therapeutics go public?
  • Is Grace Therapeutics in the S&P 500?
  • Is Grace Therapeutics in the NASDAQ 100?
  • Is Grace Therapeutics in the Dow Jones?
  • When was Grace Therapeutics's last earnings report?
  • When does Grace Therapeutics report earnings?
  • Should I buy Grace Therapeutics stock now?

What is the ticker symbol for Grace Therapeutics?

The ticker symbol for Grace Therapeutics is NASDAQ:GRCE

Does Grace Therapeutics pay dividends?

No, Grace Therapeutics does not pay dividends

What sector is Grace Therapeutics in?

Grace Therapeutics is in the Healthcare sector

What industry is Grace Therapeutics in?

Grace Therapeutics is in the Biotechnology industry

What country is Grace Therapeutics based in?

Grace Therapeutics is headquartered in United States

When did Grace Therapeutics go public?

Grace Therapeutics's initial public offering (IPO) was on February 7, 2012

Is Grace Therapeutics in the S&P 500?

No, Grace Therapeutics is not included in the S&P 500 index

Is Grace Therapeutics in the NASDAQ 100?

No, Grace Therapeutics is not included in the NASDAQ 100 index

Is Grace Therapeutics in the Dow Jones?

No, Grace Therapeutics is not included in the Dow Jones index

When was Grace Therapeutics's last earnings report?

Grace Therapeutics's most recent earnings report was on Feb 13, 2025

When does Grace Therapeutics report earnings?

The next expected earnings date for Grace Therapeutics is Jun 20, 2025

Should I buy Grace Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page